SCHEMBL145307

SCHEMBL145307

O=C(O)N1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16904 1.00 ALDH1A1 (0.42) —
SCHEMBL9079929 1.00 ALDH1A1 (0.42) —
SCHEMBL28468317 1.00 ALDH1A1 (0.42) —
SCHEMBL28497988 0.96 ALDH1A1 (0.40) —
Hydrochloric Acid SCHEMBL10787986 0.96 ALDH1A1 (0.40) —
SCHEMBL21809205 0.89 ALDH1A1 (0.55) —
SCHEMBL27087746 0.87 ALDH1A1 (0.35) —
SCHEMBL76824 0.85 — —
SCHEMBL31156371 0.85 ALDH1A1 (0.38) —
SCHEMBL153114 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361490-A1 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA CELLVIE AG (CH) 2025-11-27 — — US claimed
EP-4535996-A1 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA cellvie AG (CH) 2025-04-16 — — EP claimed
CN-119365073-A Compositions and methods for cryopreserving mitochondria 赛立维公司 2025-01-24 — — CN claimed
WO-2023237789-A1 COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA CELLVIE AG (CH) 2023-12-14 — — WO claimed
EP-2903979-B1 NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES INHIBIKASE THERAPEUTICS INC (US) 2020-08-19 — — EP claimed
EP-2557133-B1 Method for providing PVC structures for adhesive applications ROHM & HAAS (US) 2016-11-16 — — EP claimed
US-20150080318-A1 Compositions for the Treatment or Prophylaxis of Viral Infections KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2015-03-19 — — US claimed
US-8912163-B2 Compositions for the treatment or prophylaxis of viral infections KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-12-16 — — US claimed
US-20130338096-A1 Compositions for the Treatment or Prophylaxis of Viral Infections CONSEJO SUPERIOR DE INVESTIGACIONES CEINTIFICAS (ES) 2013-12-19 — — US claimed
US-8513215-B2 Compositions for the treatment or prophylaxis of viral infections KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2013-08-20 — — US claimed
EP-1620130-A1 PRODRUGS CLEAVABLE BY CD26 K.U. Leuven Research & Development (BE) 2006-02-01 — — EP claimed
WO-2004098644-A1 PRODRUGS CLEAVABLE BY CD26 K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2004-11-18 — — WO claimed
WO-2004093643-A2 MAGNETICALLY CONTROLLABLE DRUG AND GENE DELIVERY STENTS THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2004-11-04 — — WO claimed
US-20040171555-A1 Prodrugs of DP IV-inhibitors PROBIODRUG (DE) 2004-09-02 — — US claimed
US-20020049164-A1 Prodrugs of DP IV-inhibitors PROSIDION LIMITED (GB) 2002-04-25 — — US claimed
US-20010020006-A1 Compounds of unstable DP IV-inhibitors PROSIDION LIMITED (GB) 2001-09-06 — — US claimed
CN-1306541-A Compound for unstable dipeptidyl peptidase IV inhibitors PROBIODRUG GES FUR ARZNEIMITTE (DE) 2001-08-01 — — CN claimed
CN-1306540-A Prodrugs of dipeptidyl peptidase IV inhibitors PROBIODRUG GES FUR ARZNEIMITTE (DE) 2001-08-01 — — CN claimed
WO-1993011669-A1 USE OF 3-PHENYLURACIL DERIVATIVES FOR THE DESICCATION AND ABSCISSION OF PLANT PARTS BASF AKTIENGESELLSCHAFT (DE) 1993-06-24 — — WO claimed
EP-0078853-B1 PROCESS FOR PREPARING BETA-CHLOROALANINE MITSUI TOATSU CHEMICALS, Inc. (JP) 1985-11-13 — — EP claimed
Send feedback